{
    "Trade/Device Name(s)": [
        "BD MAX Enteric Viral Panel",
        "BD MAX System",
        "BD FecalSwab Collection, Transport and Preservation System",
        "Copan FecalSwab Collection, Preservation, and Transport System"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K220607",
    "Predicate Device Reference 510(k) Number(s)": [
        "K181427"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PCH",
        "OOI"
    ],
    "Summary Letter Date": "March 1, 2022",
    "Summary Letter Received Date": "March 2, 2022",
    "Submission Date": "March 1, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3990"
    ],
    "Regulation Name(s)": [
        "Gastrointestinal Microorganism Multiplex Nucleic Acid-Based Assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Norovirus GI",
        "Norovirus GII",
        "Rotavirus A",
        "Adenovirus F40/41",
        "Sapovirus (genogroups I, II, IV, V)",
        "Human Astrovirus (hAstro)"
    ],
    "Specimen Type(s)": [
        "Unpreserved stool",
        "Cary-Blair preserved stool"
    ],
    "Specimen Container(s)": [
        "BD MAX Sample Buffer Tube (SBT)",
        "Cary-Blair plastic container",
        "FecalSwab transport medium tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD MAX System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Fluorogenic gene-specific hybridization probe detection",
        "Hydrolysis probe (TaqMan)"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Multiplex PCR",
        "Automated sample preparation",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Specimen collection device",
        "Transport medium",
        "Extraction kit",
        "Detection system",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for BD MAX Enteric Viral Panel utilizing real-time PCR on the BD MAX System to detect and differentiate enteric viral pathogens from stool specimens including validation of FecalSwab specimen collection.",
    "Indications for Use Summary": "Automated in vitro diagnostic test for direct qualitative detection and differentiation of Norovirus GI/GII, Rotavirus A, Adenovirus F40/41, Sapovirus (genogroups I, II, IV, V), and Human Astrovirus nucleic acids from unpreserved or Cary-Blair preserved stool specimens from symptomatic patients with suspected acute gastroenteritis, enteritis or colitis, as an aid in differential diagnosis, used in conjunction with clinical presentation, laboratory findings, and epidemiological information.",
    "fda_folder": "Microbiology"
}